Target- |
MechanismEnzyme replacements |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date18 Dec 2012 |
100 Clinical Results associated with MediWound Germany GmbH
0 Patents (Medical) associated with MediWound Germany GmbH
100 Deals associated with MediWound Germany GmbH
100 Translational Medicine associated with MediWound Germany GmbH